Valeria V Kleandrova (V V Kleandrova)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Topics

Molecular Docking

Respiratory Syncytial Virus

Top Venues

Expert opinion on drug discovery

Future medicinal chemistry

Molecular diversity

This page only lists publications with an associated author ORCID identifier.

Publications

Valeria V Kleandrova, Maria Natália Dias Soeiro Cordeiro, Alejandro Speck-Planche
Ligand-Based Approach for Multi-Target Drug Discovery: PTML Modeling of Triple-Target Inhibitors. Current topics in medicinal chemistry (2024)
Valeria V Kleandrova, Maria Natália Dias Soeiro Cordeiro, Alejandro Speck-Planche
Current in silico methods for multi-target drug discovery in early anticancer research: the rise of the perturbation-theory machine learning approach. Future medicinal chemistry (2023)
Valeria V Kleandrova, Maria Natália Dias Soeiro Cordeiro, Alejandro Speck-Planche
Optimizing drug discovery using multitasking models for quantitative structure-biological effect relationships: an update of the literature. Expert opinion on drug discovery (2023)
Alejandro Speck-Planche, Valeria V Kleandrova
Multi-Condition QSAR Model for the Virtual Design of Chemicals with Dual Pan-Antiviral and Anti-Cytokine Storm Profiles. ACS omega 7 (36) (2022)
Valeria V Kleandrova, Alejandro Speck-Planche
PTML Modeling for Pancreatic Cancer Research: In Silico Design of Simultaneous Multi-Protein and Multi-Cell Inhibitors. Biomedicines 10 (2) (2022)
Alejandro Speck-Planche, Valeria V Kleandrova
The latest guidance on the simultaneous design of virtually active and non-hemolytic peptides. Expert opinion on drug discovery 17 (10) (2022)
Alejandro Speck-Planche, Valeria V Kleandrova, Marcus Tullius Scotti
In Silico Drug Repurposing for Anti-Inflammatory Therapy: Virtual Search for Dual Inhibitors of Caspase-1 and TNF-Alpha. Biomolecules 11 (12) (2021)
Valeria V Kleandrova, Marcus Tullius Scotti, Alejandro Speck-Planche
Computational Drug Repurposing for Antituberculosis Therapy: Discovery of Multi-Strain Inhibitors. Antibiotics (Basel, Switzerland) 10 (8) (2021)
Valeria V Kleandrova, Julio A Rojas-Vargas, Marcus Tullius Scotti, Alejandro Speck-Planche
PTML modeling for peptide discovery: in silico design of non-hemolytic peptides with antihypertensive activity. Molecular diversity (2021)
Valeria V Kleandrova, Alejandro Speck-Planche
The urgent need for pan-antiviral agents: from multitarget discovery to multiscale design. Future medicinal chemistry 13 (1) (2020)
Valeria V Kleandrova, Marcus Tullius Scotti, Luciana Scotti, Anuraj Nayarisseri, Alejandro Speck-Planche
Cell-based multi-target QSAR model for design of virtual versatile inhibitors of liver cancer cell lines. SAR and QSAR in environmental research 31 (11) (2020)